text:  And at the conference, two different people came up to me and said, I tried to get this to work, and we gave up. And I can't believe you guys got it to work. They're like, there's only five labs in the whole world that can do this. And I was like, yeah, well, it took us four years. Owen says the process was developed to treat hemophilia, but could be used to treat cancer or manufacture antibodies in the future. If officials sought your preference for the topic of a high-tech conference, what would you say?